Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.carbpol.2020.116800 http://scihub22266oqcxt.onion/10.1016/j.carbpol.2020.116800 33049807!7434482!33049807     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 261.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 261.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Carbohydr+Polym 2020 ; 250 (ä): 116800 Nephropedia Template TP {{tp|p=33049807|t=2020. A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers |pdf=|usr=}}{{33049807}} gab.com Text A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers JO: Carbohydr Polym http://www.kidney.de/pget.php?&tw=1&pmid=33049807 #FOAvip Chitosan, as a biodegradable and biocompatible polymer, is characterized by anti-microbial and anti-cancer properties. It lately has received a widespread interest for use as the pulmonary particulate backbone materials of drug carrier for the treatment of infectious disease and cancer. The success of chitosan as pulmonary particulate drug carrier is a critical interplay of their mucoadhesive, permeation enhancement and site/cell-specific attributes. In the case of nanocarriers, various microencapsulation and micro-nano blending systems have been devised to equip them with an appropriate aerodynamic character to enable efficient pulmonary aerosolization and inhalation. The late COVID-19 infection is met with acute respiratory distress syndrome and cancer. Chitosan and its derivatives are found useful in combating HCoV and cancer as a function of their molecular weight, substituent type and its degree of substitution. The interest in chitosan is expected to rise in the next decade from the perspectives of drug delivery in combination with its therapeutic performance. Twit Text FOAVip A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers ????Carbohydr Polym http://www.kidney.de/pget.php?&tw=1&pmid=33049807 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33049807 #FOAvip English Wikipedia <ref>{{Cite pmid|33049807}}</ref> A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers #MMPMID33049807 Rasul RM; Tamilarasi Muniandy M; Zakaria Z; Shah K; Chee CF; Dabbagh A; Rahman NA; Wong TW Carbohydr Polym 2020[Dec]; 250 (ä): 116800 PMID33049807show ga Chitosan, as a biodegradable and biocompatible polymer, is characterized by anti-microbial and anti-cancer properties. It lately has received a widespread interest for use as the pulmonary particulate backbone materials of drug carrier for the treatment of infectious disease and cancer. The success of chitosan as pulmonary particulate drug carrier is a critical interplay of their mucoadhesive, permeation enhancement and site/cell-specific attributes. In the case of nanocarriers, various microencapsulation and micro-nano blending systems have been devised to equip them with an appropriate aerodynamic character to enable efficient pulmonary aerosolization and inhalation. The late COVID-19 infection is met with acute respiratory distress syndrome and cancer. Chitosan and its derivatives are found useful in combating HCoV and cancer as a function of their molecular weight, substituent type and its degree of substitution. The interest in chitosan is expected to rise in the next decade from the perspectives of drug delivery in combination with its therapeutic performance. |Anti-Infective Agents/*chemistry/pharmacology/therapeutic use[MESH] |Antineoplastic Agents/*chemistry/pharmacology/therapeutic use[MESH] |Betacoronavirus/isolation & purification[MESH] |Biocompatible Materials/chemistry[MESH] |COVID-19[MESH] |Cell Survival/drug effects[MESH] |Chitosan/*analogs & derivatives[MESH] |Coronavirus Infections/drug therapy/pathology/virology[MESH] |Drug Carriers/*chemistry[MESH] |Humans[MESH] |Lung Neoplasms/pathology[MESH] |Pandemics[MESH] |Pneumonia, Viral/drug therapy/pathology/virology[MESH]A review on chitosan and its development as pulmonary particulate anti(epmc).pdf DeepDyve Pubget Overpricing